Endoscopy 2000; 32(8): 604-608
DOI: 10.1055/s-2000-16506
Original Article

Georg Thieme Verlag Stuttgart ·New York

Unrecognizable Intramucosal Spread of Diffuse-Type Mucosal Gastric Carcinomas of Less than 20 mm in Size

Y. Ninomiya, A. Yanagisawa, Y. Kato, H. Tomimatsu
  • Dept. of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research (JFCR), Tokyo, Japan
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Background: Diffuse-type intramucosal gastric carcinomas sometimes spread within the mucosa beyond their macroscopic margins, often causing positive resection margins upon local resections such as endoscopic mucosal resection.

Patients and Methods: A consecutive series of 34 patients with solitary, small (less than 20 mm in diameter macroscopically), and macroscopically well demarcated diffuse-type mucosal carcinomas, who were treated with gastrectomy followed by detailed pathological examination, were included in the present study. Unrecognizable intramucosal spread is defined as an area of cancer which is indistinguishable macroscopically from its peripheral noncancerous area, and covered by normal epithelium with neither morphologic nor color changes. We examined the extent of unrecognizable intramucosal spread, measuring the maximum distances between macroscopic and microscopic margins on the sections, and investigated its relationship with four factors: location of the lesion, macroscopic size, histologic ulcer formation, and degree of atrophy of the background mucosa.

Results: The maximum distance between macroscopic and microscopic margins was significantly larger (maximum 10 mm) in the background mucosas with marked atrophy than in those with little or no atrophy. No other factors, including location, macroscopic size and ulcer formation, correlated with it.

Conclusion: We should pay particular attention to unrecognizable intramucosal spread, especially in markedly atrophied mucosa, when treating small diffuse-type mucosal gastric cancer by local resections such as endoscopic mucosal resection. In addition, because of unrecognizable intramucosal spread, a surgical incision margin of at least 10 mm from the macroscopic margin is indicated.

References

  • 1 Yamao T, Shirao K, Ono H, et al. Risk factors for lymph node metastasis from intramucosal gastric carcinoma.  Cancer. 1996;  77 602-606
  • 2 Kato Y, Yanagisawa A, Utsude T, et al. Safer and more reliable endoscopic mucosal resection (EMR) in the treatment of early gastric carcinomas - from a pathological standpoint (in Japanese).  Endoscopica Digestiva. 1993;  5 1153-1159
  • 3 Nakano K, Yanagisawa A, Utsude T, et al. Limits of indication of endoscopic mucosal resection (EMR) for treatment of early gastric carcinoma of undifferentiated type - from a pathological viewpoint (in Japanese).  Stomach Intestine. 1995;  30 (10) 1289-1294
  • 4 Nakamura K, Sugano H, Kato Y. A boundary line limited to the fundic gland mucosa with intestinal metaplasia - its shifting with increasing age and clinicopathological significances (in Japanese).  Stomach Intestine. 1980;  15 (2) 125-136
  • 5 Sano T, Kobori O, Muto T. Lymph node metastasis from early gastric cancer: endoscopic resection of tumor.  Br J Surg. 1992;  79 241-244
  • 6 Iwashita A, Yamada Y, Arita M, et al. Indication of endoscopic curative resection for early gastric carcinoma from a pathologic point of view (in Japanese).  Stomach Intestine. 1991;  26 265-274
  • 7 Noda M, Kodama T, Nakajima M, et al. Possibilities and limitations of endoscopic resection for early gastric cancer.  Endoscopy. 1997;  29 361-365
  • 8 Amano Y, Ishihara S, Amano K, et al. An assessment of local curability of endoscopic surgery in early gastric cancer without satisfaction of current therapeutic indications.  Endoscopy. 1998;  30 (6) 548-552
  • 9 Ashida K, Egashira Y, Tanaka M, et al. Early gastric cancer with remains of cancer cells extensively in the mucosa by EMR: report of a case (in Japanese).  Stomach Intestine. 1996;  31 1139-1143

Y. Ninomiya

Dept. of Pathology
The Cancer Institute of the Japanese Foundation for Cancer Research

170-8455
Kami-Ikebukuro 1-37-1
Toshima-ku
Tokyo
Japan


Fax: Fax:+ 81-3-53943893

Email: E-mail:n7653710100@mn.tokyo.jcom.ne.jp